{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T03:31:50Z","timestamp":1773113510193,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"crossref","award":["No. 2021M3E5E3081425"],"award-info":[{"award-number":["No. 2021M3E5E3081425"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"crossref","award":["RS-2023 00227944"],"award-info":[{"award-number":["RS-2023 00227944"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Mid-Career Bridging Program through Seoul National University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11885-4","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T12:33:01Z","timestamp":1762777981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of ACEI\/ARB use on COVID-19 mortality in patients with ischaemic heart disease: insights from South Korean National health insurance service data"],"prefix":"10.1186","volume":"25","author":[{"given":"Shin-Woo","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taewan","family":"Goo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seunghwan","family":"Noh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seungyeoun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bumjo","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taesung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"issue":"8","key":"11885_CR1","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1161\/CIRCRESAHA.121.317997","volume":"128","author":"MK Chung","year":"2021","unstructured":"Chung MK, Zidar DA, Bristow MR, Cameron SJ, Chan T, Clifford V, Harding I, et al. COVID-19 and cardiovascular disease: from bench to bedside. Circ Res. 2021;128(8):1214.","journal-title":"Circ Res"},{"issue":"9","key":"11885_CR2","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41569-020-0413-9","volume":"17","author":"M Nishiga","year":"2020","unstructured":"Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020;17(9):543.","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"11885_CR3","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/cpt.1863","volume":"108","author":"K Sriram","year":"2020","unstructured":"Sriram K, Insel PA. Risks of ACE inhibitor and ARB usage in COVID-19: evaluating the evidence. Clin Pharmacol Ther. 2020;108(2):236\u201341.","journal-title":"Clin Pharmacol Ther"},{"issue":"24","key":"11885_CR4","doi-asserted-by":"publisher","first-page":"e023535","DOI":"10.1161\/JAHA.121.023535","volume":"10","author":"Michael Pan","year":"2021","unstructured":"Pan M, Vasbinder A, Anderson E, Catalan T, Shadid HR, Berlin H et al. Angiotensin-Converting enzyme Inhibitors, angiotensin II receptor Blockers, and outcomes in patients hospitalized for COVID\u201019. J Am Heart Assoc. 2021.","journal-title":"Journal of the American Heart Association"},{"issue":"12","key":"11885_CR5","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","volume":"126","author":"P Zhang","year":"2020","unstructured":"Zhang P, Zhu L, Cai J, Lei F, Qin J-J, Xie J, et al. Association of inpatient use of angiotensin-Converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res. 2020;126(12):1671.","journal-title":"Circ Res"},{"issue":"2","key":"11885_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1161\/HYPERTENSIONAHA.120.15572","volume":"76","author":"X Guo","year":"2020","unstructured":"Guo X, Zhu Y, Hong Y. Decreased mortality of COVID-19 with Renin-Angiotensin-Aldosterone system inhibitors therapy in patients with hypertension: A Meta-Analysis. Hypertension. 2020;76(2):13\u20134.","journal-title":"Hypertension"},{"issue":"6","key":"11885_CR7","doi-asserted-by":"publisher","first-page":"e00666","DOI":"10.1002\/prp2.666","volume":"8","author":"A Kurdi","year":"2020","unstructured":"Kurdi A, Abutheraa N, Akil L, Godman B. A systematic review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 clinical outcomes: what is the evidence so far? Pharmacol Res Perspect. 2020;8(6):e00666.","journal-title":"Pharmacol Res Perspect"},{"key":"11885_CR8","doi-asserted-by":"publisher","first-page":"100627","DOI":"10.1016\/j.ijcha.2020.100627","volume":"31","author":"Daniel Caldeira","year":"2020","unstructured":"Caldeira D, Alves M, Melo RGe, Ant\u00f3nio PS, Cunha N, Nunes-Ferreira A et al. Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers and the risk of COVID-19 infection or severe disease: systematic review and meta-analysis. Int J Cardiol Heart Vasculature. 2020;31.","journal-title":"International Journal of Cardiology Heart & Vasculature"},{"key":"11885_CR9","doi-asserted-by":"crossref","unstructured":"Singh R, Rathore SS, Khan H, Bhurwal A, Sheraton M, Ghosh P et al. Mortality and severity in COVID-19 patients on aceis and ARBs\u2014A systematic Review, Meta-Analysis, and Meta-Regression analysis. Front Med. 2021;8.","DOI":"10.3389\/fmed.2021.703661"},{"issue":"11","key":"11885_CR10","doi-asserted-by":"publisher","first-page":"e025289","DOI":"10.1161\/JAHA.122.025289","volume":"11","author":"Jordan Loader","year":"2022","unstructured":"Loader J, Taylor FC, Lampa E, Sundstr\u00f6m J. Renin-Angiotensin aldosterone system inhibitors and COVID\u201019: A systematic review and Meta\u2010Analysis revealing critical bias across a body of observational research. J Am Heart Association: Cardiovasc Cerebrovasc Disease. 2022;11(11).","journal-title":"Journal of the American Heart Association"},{"issue":"1","key":"11885_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000512592","volume":"64","author":"Mohitosh Biswas","year":"2021","unstructured":"Biswas M, Rahaman S, Biswas TK, Haque Z, Ibrahim B. Association of Sex, Age, and comorbidities with mortality in COVID-19 patients: A systematic review and Meta-Analysis. Intervirology. 2020;1\u201312.","journal-title":"Intervirology"},{"issue":"9","key":"11885_CR12","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1177\/2047487320915663","volume":"28","author":"M Gatti","year":"2021","unstructured":"Gatti M, Antonazzo IC, Diemberger I, De Ponti F, Raschi E. Adverse events with sacubitril\/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system. Eur J Prev Cardiol. 2021;28(9):983\u20139.","journal-title":"Eur J Prev Cardiol"},{"issue":"12","key":"11885_CR13","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s10654-020-00698-1","volume":"35","author":"AT Levin","year":"2020","unstructured":"Levin AT, Hanage WP, Owusu-Boaitey N, Cochran KB, Walsh SP, Meyerowitz-Katz G. Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications. Eur J Epidemiol. 2020;35(12):1123\u201338.","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"11885_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/jpm11020116","volume":"11","author":"TK Oh","year":"2021","unstructured":"Oh TK, Song I-A, Jeon Y-T. Statin therapy and the risk of COVID-19: A cohort study of the National health insurance service in South Korea. J Pers Med. 2021;11(2):116.","journal-title":"J Pers Med"},{"issue":"5","key":"11885_CR15","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3346\/jkms.2017.32.5.718","volume":"32","author":"JA Kim","year":"2017","unstructured":"Kim JA, Yoon S, Kim LY, Kim DS. Towards actualizing the value potential of Korea health insurance review and assessment (HIRA) data as a resource for health research: Strengths, Limitations, Applications, and strategies for optimal use of HIRA data. J Korean Med Sci. 2017;32(5):718\u201328.","journal-title":"J Korean Med Sci"},{"issue":"4","key":"11885_CR16","doi-asserted-by":"publisher","first-page":"552","DOI":"10.4093\/dmj.2022.0193","volume":"46","author":"MK Kim","year":"2022","unstructured":"Kim MK, Han K, Lee S-H. Current trends of big data research using the Korean National health information database. Diabetes Metab J. 2022;46(4):552\u201363.","journal-title":"Diabetes Metab J"},{"issue":"7","key":"11885_CR17","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/aje\/kwq439","volume":"173","author":"MJ Funk","year":"2011","unstructured":"Funk MJ, Westreich D, Wiesen C, St\u00fcrmer T, Brookhart MA, Davidian M. Doubly robust Estimation of causal effects. Am J Epidemiol. 2011;173(7):761\u20137.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"11885_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1214\/aos\/1176346391","volume":"12","author":"J. N. K. Rao","year":"1984","unstructured":"Rao JN, Scott AJ. On chi-squared tests for multiway contingency tables with cell proportions estimated from survey data. Annals Stat. 1984:46\u201360.","journal-title":"The Annals of Statistics"},{"issue":"2","key":"11885_CR19","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/ije\/dyr218","volume":"41","author":"MJ Knol","year":"2012","unstructured":"Knol MJ, VanderWeele TJ. Recommendations for presenting analyses of effect modification and interaction. Int J Epidemiol. 2012;41(2):514\u201320.","journal-title":"Int J Epidemiol"},{"issue":"3","key":"11885_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.annepidem.2006.10.009","volume":"17","author":"R Li","year":"2007","unstructured":"Li R, Chambless L. Test for additive interaction in proportional hazards models. Ann Epidemiol. 2007;17(3):227\u201336.","journal-title":"Ann Epidemiol"},{"issue":"3","key":"11885_CR21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/bdcc5030030","volume":"5","author":"D Riswantini","year":"2021","unstructured":"Riswantini D, Nugraheni E, Arisal A, Khotimah PH, Munandar D, Suwarningsih W. Big data research in fighting COVID-19: contributions and techniques. Big Data Cogn Comput. 2021;5(3):30.","journal-title":"Big Data Cogn Comput"},{"issue":"2","key":"11885_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jinf.2020.04.021","volume":"81","author":"Z Zheng","year":"2020","unstructured":"Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020;81(2):16\u201325.","journal-title":"J Infect"},{"issue":"3","key":"11885_CR23","doi-asserted-by":"publisher","first-page":"e213594","DOI":"10.1001\/jamanetworkopen.2021.3594","volume":"4","author":"R Baral","year":"2021","unstructured":"Baral R, Tsampasian V, Debski M, Moran B, Garg P, Clark A, et al. Association between Renin-Angiotensin-Aldosterone system inhibitors and clinical outcomes in patients with COVID-19: A systematic review and Meta-analysis. JAMA Netw Open. 2021;4(3):e213594.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"11885_CR24","doi-asserted-by":"publisher","first-page":"6317","DOI":"10.1038\/s41467-020-19741-6","volume":"11","author":"H Peckham","year":"2020","unstructured":"Peckham H, de Gruijter NM, Raine C, Radziszewska A, Ciurtin C, Wedderburn LR, et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun. 2020;11(1):6317.","journal-title":"Nat Commun"},{"key":"11885_CR25","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.puhe.2020.05.006","volume":"183","author":"JA Patel","year":"2020","unstructured":"Patel JA, Nielsen FBH, Badiani AA, Assi S, Unadkat VA, Patel B, et al. Poverty, inequality and COVID-19: the forgotten vulnerable. Public Health. 2020;183:110\u20131.","journal-title":"Public Health"},{"key":"11885_CR26","doi-asserted-by":"crossref","unstructured":"Wang X, Fang X, Cai Z, Wu X, Gao X, Min J et al. Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: a systemic review and meta-analysis. Research. 2020.","DOI":"10.34133\/2020\/2402961"},{"issue":"5","key":"11885_CR27","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3390\/life14050545","volume":"14","author":"P Karakasis","year":"2024","unstructured":"Karakasis P, Nasoufidou A, Sagris M, Fragakis N, Tsioufis K. Vascular alterations following COVID-19 infection: A comprehensive literature review. Life. 2024;14(5):545.","journal-title":"Life"},{"issue":"7","key":"11885_CR28","doi-asserted-by":"publisher","first-page":"6049","DOI":"10.18632\/aging.103000","volume":"12","author":"B Wang","year":"2020","unstructured":"Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging. 2020;12(7):6049\u201357.","journal-title":"Aging"},{"issue":"8","key":"11885_CR29","doi-asserted-by":"publisher","first-page":"e0238215","DOI":"10.1371\/journal.pone.0238215","volume":"15","author":"P Ssentongo","year":"2020","unstructured":"Ssentongo P, Ssentongo AE, Heilbrunn ES, Ba DM, Chinchilli VM. Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis. PLoS ONE. 2020;15(8):e0238215.","journal-title":"PLoS ONE"},{"issue":"3","key":"11885_CR30","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1001\/jama.2020.25864","volume":"325","author":"RD Lopes","year":"2021","unstructured":"Lopes RD, Macedo AVS, de Barros E, Silva PGM, Moll-Bernardes RJ, Dos Santos TM, Mazza L, et al. Effect of discontinuing vs continuing angiotensin-Converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: A randomized clinical trial. JAMA. 2021;325(3):254\u201364.","journal-title":"JAMA"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11885-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11885-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11885-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:15:36Z","timestamp":1762884936000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11885-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11885"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11885-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"25 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Seoul National University Institutional Review Board (IRB No. E2112\/001\u2013003). The IRB determined that the requirement for informed consent was waived because the analyses were conducted retrospectively using anonymized data derived from the South Korean National Health Insurance Service (NHIS) database. The use of NHIS data was additionally approved by the Health Insurance Review and Assessment Service (NHIS-2022-1-549). All procedures of this study were conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1529"}}